Put Options

7 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2024

May 07, 2024

BUY
$0.5 - $0.73 $14,600 - $21,316
29,200 Added 30.48%
125,000 $66,000
Q4 2023

Feb 14, 2024

SELL
$0.48 - $0.7 $105,360 - $153,650
-219,500 Reduced 69.62%
95,800 $54,000
Q3 2023

Nov 14, 2023

SELL
$0.5 - $1.05 $9,850 - $20,685
-19,700 Reduced 5.88%
315,300 $189,000
Q2 2023

Aug 11, 2023

SELL
$0.55 - $0.89 $188,925 - $305,715
-343,500 Reduced 50.63%
335,000 $254,000
Q1 2023

May 16, 2023

SELL
$0.68 - $1.25 $108,460 - $199,375
-159,500 Reduced 19.03%
678,500 $481,000
Q4 2022

Feb 14, 2023

SELL
$0.96 - $1.34 $683,520 - $954,080
-712,000 Reduced 45.94%
838,000 $863,000
Q3 2022

Nov 14, 2022

SELL
$1.02 - $2.23 $480,012 - $1.05 Million
-470,600 Reduced 23.29%
1,550,000 $2.05 Million

Others Institutions Holding SENS

About Senseonics Holdings, Inc.


  • Ticker SENS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 465,447,008
  • Market Cap $186M
  • Description
  • Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with ...
More about SENS
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.